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A B S T R A C T   
Background: Endovascular thrombectomy is the process of removing a blood clot and re-establishing blood flow 
in patients with emergent large vessel occlusion. The technique provides an opportunity to deliver therapeutics 
directly to the site of injury. The intra-arterial (IA) route of drug administration in the mouse was developed to 
bridge the gap between animal stroke treatments and clinical stroke therapy. Here, we adapted the IA method for 
use in rats, by investigating various flow rates to optimize the IA injection through the internal carotid artery 
(ICA). 
Methods: Male and female Sprague-Dawley rats (~4 months of age) were subjected to placement of micro-angio 
tubing at the bifurcation of the common carotid artery for injection into the ICA. We evaluated a range of 
infusion rates of carbon black ink and its vascular distribution within the brain. 
Results: Optimal injection rates in males was 4− 6 μl/min and 2− 4 μl/min in females. The IA injection using these 
sex-specific rates resulted in appropriate limited dye delivery to only the ipsilateral region of the brain, without 
inducing a subarachnoid hemorrhage. 
Conclusion: Upon adapting the IA administration model to rats, it was determined that the rate of infusion varied 
between males and females. This variability is an important consideration for studies utilizing both sexes, such as 
in ischemic stroke studies.   
1. Introduction 
Intra-arterial (IA) injection through the internal carotid artery (ICA) 
allows for a targeted delivery of therapeutics directly to the brain (Zink, 
Foley et al. 2009; Guo, Ge et al. 2013). Animal studies using IA injection 
through the ICA have been combined with an intra-luminal filament 
middle cerebral artery occlusion (MCAO) surgery model (Guo, Ge et al. 
2013; Azedi, Mehrpour et al. 2019). The combination of IA injection and 
MCAO is a translational approach to mimic drug administration during 
an endovascular thrombectomy procedure in ischemic stroke patients. 
For studies of brain injury, IA injection of compounds through the 
ICA allows for targeted administration without prior systemic circula-
tion, increasing efficacy. Importantly, IA has a low mortality rate asso-
ciated with the procedure (Santillan, Rubin et al. 2014). In a mouse 
study by Maniskas et al., the rate and volume of injection were shown to 
be important factors for targeted delivery (Maniskas, Bix et al. 2015). 
They demonstrated how different injection flow rates and volumes 
through the ICA of mice had either a direct, targeted delivery to the 
brain or a systemic delivery throughout the body. In rat studies, IA in-
jections have been performed through the ICA (Zink, Foley et al. 2009), 
femoral artery (Staudacher, Sela et al. 2011), and the subclavian artery 
(Hayashi, Tomimatsu et al. 2006). However, there have not been any 
studies aimed at optimizing the injection process itself. Here, we 
investigated the effects of various flow rates to optimize IA injection 
through the ICA in male and female rats. When combined with MCAO in 
future studies, this would allow for optimal delivery of compounds 
directly to the ischemic region. 
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2. Materials and methods 
2.1. Materials 
A 15 cm length of Micro-renathane implantation tubing (0.025” x 
0.012”; Braintree Scientific, MRE025) was used for delivery of com-
pounds into the external carotid artery (ECA), through the ICA, and to 
the brain. A 30 G removable needle (0.5” with point 3 tip; Hamilton 
Syringe Co, #7803-07) was attached to the tubing and screwed onto a 
100 μl Hamilton gas tight syringe (Hamilton Syringe Co. 7656-01), 
which was then placed into a syringe pump (Braintree Scientific, BS- 
8000). Two vascular clamps (Micro-serrines, FST-18055-01) were used 
for the occlusion of the common carotid artery (CCA) and ICA. Three, 9 
cm sections of 5-0 silk suture was used to tie off the proximal and distal 
portions of the ECA, and for securing the implantation tubing into the 
ECA. 
2.2. Animal and surgical preparation 
The experimental protocol was approved by the Institutional Animal 
Care and Use Committee of the University of Kentucky and experiments 
were performed in accordance with the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health. This study used 
Sprague Dawley rats (Envigo; approximately 4 months old) with an N =
21 males (n = 3/injection rate) weighing between 380− 500 g with a 
mean of 415 g, and an N = 23 females (n = 3− 4/injection rate) weighing 
between 220− 350 g with a mean of 264 g. As this was an exploratory 
study rather than a confirmatory study, power calculations were not 
used, and smaller groups sizes were favored. All rats were housed in a 
climate-controlled room on a 14/10 h light/dark cycle and food and 
water were provided ad libitum. Pre-op analgesic (Carprofen 50 mg/mL, 
diluted with saline to 5 mg/mL; dosed at 5 mg/kg s.c.) and Atropine 
(0.54 mg/mL, diluted with saline to 0.108 mg/mL; dosed at 0.04 mg/kg 
s.c.) was given subcutaneously based on body weight. Rats were placed 
in an induction chamber and anesthetized using 5% isoflurane with 1 L 
of oxygen. The cervical neck region was shaved from the mandible to the 
top of the sternum, and cleaned with Hibiclens (chlorhexidine scrub) 
prior to 70 % EtOH and then a betadine solution. Anesthesia was 
maintained with a nosecone that received 2.5 % Isoflurane with 1 L of 
oxygen. Since our laboratory will eventually combine the IA procedure 
with the MCAO stroke surgery, these rats did not receive any heat 
support during the procedure, as heat increases mortality in our stroked 
rats. 
2.3. Isolation of the CCA and ECA/ICA bifurcation 
A midline (vertical) neck incision was performed and the salivary 
glands were separated to visualize the trachea. The sternocleidomastoid 
muscle (SCM), located adjacent to the trachea, and was pulled away 
from the target area using lone star hooks. The planar omohyoid muscle 
covering the carotid sheath/artery was blunt dissected (Fig. 1A) and fat 
and connective tissue was removed to expose the CCA and vagus nerve, 
which were carefully separated. This continued anteriorly to isolate the 
internal carotid (ICA)/external carotid (ECA) arteries. (Fig. 1B) The 
superior thyroid artery (STA), the first collateral of the ECA, and the 
occipital artery (OA), was isolated and cauterized using fine-tipped 
curved forceps and a low-temp cautery. 
2.4. Creating the ECA Stump for tubing insertion 
Two 9-inch segments of 5− 0 silk suture were placed underneath the 
ECA. One suture was tied to ligate the ECA as far distal as possible from 
the ECA/ICA bifurcation, and the second was tied just proximal to the 
first, leaving enough space to cut between them, forming a stump 
(Fig. 1C). The proximal suture that held the ECA stump was taped down, 
providing tension when inserting the catheter tubing. Of note, creating 
the ECA stump is not necessary if you are not combining the intra- 
arterial injection with a middle cerebral artery occlusion (MCAO) sur-
gery. By cutting the ECA in half and creating a stump, it allows for easier 
insertion of a MCAO filament into the brain for occlusion. 
2.5. Injection procedure 
2.5.1. Carbon black ink and syringe prep 
A mixture of fountain inks (Pelikan-Fount India and Higgins Foun-
tain Pen India) in a 1:9 ratio was prepared fresh as previously described 
(Maniskas, Bix et al. 2015). We chose this mixture due to its low vis-
cosity and ability to permanently stain large and small vessels equally as 
previously published (Hasan, Herz et al. 2012). A 15 cm length of 
Micro-Renathane catheter tubing was attached to a 30 G removable 
needle by using fine tipped forceps under a dissecting microscope, with 
approximately 3− 4 mm of tubing placed onto the needle. We made a 45 
degree angle cut on the opposite end of the tubing for easier vessel 
insertion. The ink was loaded into the 100 μL Hamilton gas tight syringe 
at a downward 45 degree angle to prevent air bubbles from forming 
within the syringe. The needle with tubing was attached to the syringe 
and the tubing was primed with ink to remove air. 
Fig. 1. Representative images of the surgical area in the rat. (A) Visualization of the location of the trachea and the Omohyoid muscle (which is cut and removed to 
access the CCA). (B) The CCA, the ECA/ICA bifurcation off the CCA, and the vagus nerve separated after the carotid sheath was removed. (C) The distal and proximal 
suture ties on the ECA. (D) Formation of the ECA stump after cutting between the distal and proximal suture ties, and a vascular clamp added to the CCA. (E) Creation 
of a hole on the ECA stump where the catheter tubing is inserted, following the addition of a vascular clamp on the ICA. (F) Catheter tubing inserted into the ECA 
stump, and advanced to the start of the ICA. (G) Infusion of the ink into the ICA. (H) The ECA has been tied off after removal of the tubing. 
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2.5.2. Micro-angio tubing insertion into ECA 
Vascular clamps were placed onto the CCA and ICA. A small hole was 
made in the ECA stump using micro-scissors, being sure not to create a 
hole too close to the bifurcation. A small amount of blood loss occurs 
when you have successfully made a hole, but excessive bleeding is an 
indication that either the CCA or ICA are not sufficiently clamped 
(Fig. 1D-E). The prepared catheter tubing was placed into the ECA hole 
that was created and advanced to the start of the ICA within the bifur-
cation (Fig. 1F), which was best done with the use of fine tipped forceps 
0.5 cm from the tip of the tubing and tension on the proximal suture 
holding the ECA stump. A third piece of 9 inch, 5− 0 silk suture was 
placed around the ECA and catheter tubing, to temporarily anchor the 
tubing, and form a tight seal around the vessel wall. The vascular clamp 
was then removed from the ICA, then the CCA, establishing reperfusion. 
2.5.3. Ink injection flow rate and volume 
After 5 min of reperfusion, 25 μL of ink was injected at flow rates of 
2.5 μL, 3 μL, 3.5 μL, 4 μL, 4.5 μL, 5 μL, 6 μL, and 7 μL per minute for the 
male rats. The female rats were injected at flow rates of 2 μL, 2.5 μL, 3 
μL, 3.5 μL, 4 μL, 4.5 μL, and 5 μL per minute. (Fig. 1G). 
2.5.4. Removal of catheter tubing 
The catheter tubing was removed by placing vascular clamps back on 
Table 1 
IA injection rates in naive male and female rats.     
Hemisphere Staining 





(N ¼ 21 rats) 3 25 No No 
3 rats/rate 3.5 25 No No  
4 25 Yes No  
4.5 25 Yes No  
5 25 Yes No  
6 25 Yes No  
7 25 Yes Yes    
Hemisphere Staining 





(N ¼ 23 rats) 2 25 Yes No 
3− 4 rats/rate 2.5 25 Yes No  
3 25 Yes No  
3.5 25 Yes No  
4 25 Yes No  
4.5 25 Yes Yes  
5 25 Yes Yes  
Fig. 2. (A) Male rat brains stained with ink following IA injections at injection rates of 3 μL/min, 3.5 μL/min, 4 μL/min, 5 μL/min, 6 μL/min, and 7 μL/min. (B) 
Female rat brains stained with ink following IA injections at injection rates of 2 μL/min, 2.5 μL/min, 3 μL/min, 3.5 μL/min, 4 μL/min, and 5 μL/min. I: Ipsilateral 
hemisphere, C: Contralateral hemisphere. The dark area is the ink that has entered the brain. 
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the CCA and the ICA. The tubing was slowly pulled back until 
completely removed from the ECA stump. The suture was tightened to 
tie off the ECA vessel completely. The vascular clamps were removed 
from the ICA and CCA to establish reperfusion (Fig. 1H). Vessels were re- 
perfused for 5 min prior to euthanasia to assess the infusion of ink. 
2.6. Flow optimization 
Our stated goal was to optimize infusion conditions. An optimized 
injection would infuse the ink into the ipsilateral MCA territory, with 
minimal cross penetration into the contralateral hemisphere or posterior 
circulation. In addition, optimal technique would not result in any 
complication such as hemorrhage. 
3. Results 
3.1. Flow rate and injection volume 
The flow rates and volume used are based on previously reported 
data in mice (Maniskas, Bix et al. 2015). Male rats weighing between 
380− 500 g received an IA injection of carbon black ink (25 μL) at 2.5 μL, 
3 μL, 3.5 μL, 4 μL, 4.5 μL, 5 μL, 6 μL or 7 μL per minute (Table 1). In-
jection rates of 4− 6 μl/min among the male rats showed optimal IA 
infusion of ink in the ipsilateral hemisphere, with minimal staining in 
the contralateral hemisphere and no presence of hemorrhage (Fig. 2A). 
The 2.5 μL/min rate was not strong enough to overcome the blood flow 
at the CCA bifurcation in the male rats, and the ink backfilled into the 
catheter tubing. Rates of 3–3.5 μl/min in male rats took thirty seconds to 
one minute before ink entered into the ICA, and no staining in the 
ipsilateral hemisphere was observed. A rate of 7 μL/min resulted in 
contralateral staining (n = 1) (Fig. 2A) and a subarachnoid hemorrhage 
(SAH) (n = 2) (Fig. 3). Female rats weighing between 220− 350 g 
received an IA injection of carbon black ink (25 μL) at 2 μL, 2.5 μL, 3 μL, 
3.5 μL, 4 μL, 4.5 μL, and 5 μL per minute (Table 1). Injection rates of 2− 4 
μl/min among the female rats showed optimal IA infusion of ink in the 
ipsilateral hemisphere, with minimal staining in the contralateral 
hemisphere and no presence of hemorrhage (Figs. 2B and 4). An 
injection rate of 2 μL/min in the female rats showed only ipsilateral 
staining, but took approximately one minute for the ink to overcome the 
blood flow. Injection rates of 4.5− 5 μl/min in the female rats resulted in 
contralateral staining. 
4. Discussion 
The endovascular thrombectomy procedure has become a standard 
treatment protocol for stroke patients. One advantage of this procedure 
is the ability to administer compounds directly to the sight of injury, 
bypassing initial systemic circulation. This IA method is now being 
utilized in preclinical studies for targeted delivery of compounds (Jovin, 
Albers et al. 2016). Following the Stroke Therapy Academic Industry 
Roundtable (STAIR) recommendation for stroke studies (Fisher, Feuer-
stein et al. 2009; Savitz, Baron et al. 2019), we aimed to perform IA 
injections in male and female rats. When determining optimal IA in-
jection rates through the ICA, we had to consider that there would be 
differences between the males and females. Males were twice the size of 
the females at the same age, and our results prove that male rats do 
require a higher infusion rate. The total volume injected was 25 μL, 
based on work that was previously done in mice (Maniskas, Bix et al. 
2015), and worked well in rats, as it stained the entire ipsilateral 
hemisphere (Fig. 4). Injection rates of 4− 6 μl/min among the male rats 
Fig. 3. Ventral brain region of a male rat with an IA infusion of ink at 7 μL/min, 
producing the formation of a subarachnoid hemorrhage. 
Fig. 4. Image of 2 mm brain slices of a female rat with an IA infusion of ink at 
3.5 μL/min rate, with a volume of 25 μL. I: Ipsilateral hemisphere, C: Contra-
lateral hemisphere. 
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showed optimal IA infusion of ink into the ipsilateral hemisphere, with 
minimal staining in the contralateral hemisphere, and without any 
presence of a SAH. The lower rate of 2.5 μL/min did not produce enough 
force to overcome the male rats’ blood pressure within the CCA, as the 
blood would backfill the catheter tubing and clot. The rates of 3–3.5 
μl/min took at least one minute to overcome the male rats’ blood 
pressure before entering into the ICA, and resulted in no ink staining in 
the brain. The 7 μL/min infusion rate in the male rats resulted in a SAH 
(Fig. 3) and contralateral staining (Fig. 2A). On the other hand, rates of 
2− 4 μl/min among the female rats showed optimal IA infusion of ink in 
the ipsilateral hemisphere, with minimal staining in the contralateral 
hemisphere, and without any presence of a subarachnoid hemorrhage. 
Infusion rates higher than 4 μL/min in the female rats induced ink 
staining in the contralateral hemisphere (Fig. 2B). It is important to note 
that at the 2 μL/min rate in the females took approximately one minute 
for the ink to enter into the ICA, but did result in staining the ipsilateral 
hemisphere. Our focus was on a targeted delivery to the ipsilateral 
hemisphere, with minimal ink crossing over into the contralateral 
hemisphere. We also wanted to prevent any unnecessary side effects that 
resulted in the formation of a subarachnoid or petechial hemorrhage, as 
that would confound results from an ischemic stroke in future studies. 
A potential limitation of this study is the use of ink, as we do not 
know the chemical composition of the ink and it may be denser than 
compounds used in future IA injection studies. However, this combi-
nation of ink has been previously evaluated for the visualization of ce-
rebral blood vessels in mice, and it is reported the two inks are very low 
viscosity (1.1 mPa/s and 10–50 mPa/s) and the combination at a 1:9 
ratio leads to reproducible results with permanent staining through 
large and small vessels (Hasan, Herz et al. 2012). Our ongoing studies in 
stroke have found the rates do translate to our clinically relevant drugs. 
Additionally, following the Maniskas et al. publication that described 
the rates/volumes for IA injection of ink in mice, the group published 
several other studies using clinically relevant compounds (e.g., verap-
amil, nitroglycerin) at the same rate/volume (Maniskas, Roberts et al. 
2016; Fraser, Maniskas et al. 2017). Since rats are commonly used in 
preclinical studies, and rates of infusion are not previously reported, we 
optimized the IA procedure for rats. We recommend a range of infusion 
rates since the weight of male and female rats at the same age is highly 
varied, and plays a large role in the optimal rate. Future studies that 
utilize the IA injection method may be needed to optimize the rate of 
infusion based on the compound used and the weight or age of the 
animal. 
One advantage of IA injection through the ICA is the reduced sys-
temic circulation prior to reaching the target brain tissue (Arnberg, 
Samen et al. 2014). Not only is IA injection making great strides in the 
field of stroke research, it is also now being utilized in other fields such 
as cancer studies (Joshi, Cooke et al. 2017), (Huang, Boltze et al. 2020), 
CNS studies, testing the effects of steroids on rats (Dawley, 
Moeller-Bertram et al. 2009) and traumatic brain injuries (Osanai, 
Kuroda et al. 2012). The method is being adapted for larger animals, 
including canines and rabbits (Srinivasan, Gumin et al. 2020), (Lund-
berg, Jussing et al. 2017), as there is great value in the use of large 
animal models of disease for increased translation to humans (Boltze, 
Modo et al. 2019; Herrmann, Meckel et al. 2019). A proof-of-concept 
study performed in rabbits showed IA injections are safe and feasible 
in large animals. Importantly, rabbits treated with tumor infiltrating 
lymphocytes (TIL) via the IA route showed that more cells reached the 
desired target or tumor compared to IV infusions (Lundberg, Jussing 
et al. 2017). 
Mouse MCAO occlusion studies with IA injections have shown that 
ligating the pterygopalatine artery (PPA; branch off the ICA) prior to 
injection, maximizes the amount of solution that travels up to the 
ischemic region (Guo, Ge et al. 2013). In our studies, some animals 
showed ink had entered into the PPA and stained the muscle tissue, but 
the amount was minimal. Ligating the PPA is considered unnecessary for 
the MCAO occlusion model, and due to its technical difficulties and 
possible complications, few studies utilize this technique (Guo, Ge et al. 
2013; Azedi, Mehrpour et al. 2019). In turn, we also found that it wasn’t 
necessary to ligate the PPA as targeted delivery to the brain was 
achieved. 
In conclusion, the adoption of IA administration of compounds al-
lows for targeted delivery to the brain and having a better understanding 
of the effects of sex and/or weight on the infusion rate will help to 
develop specific treatments for stroke or other diseases (Haast, Gus-
tafson et al. 2012). This translational animal model combined with the 
MCAO model will provide a paradigm to develop adjuvant therapeutics 
for both male and female patients. 
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